Chapter 46. Selected Management Issues of Patients with Hodgkin Lymphoma
- Mark A. Crowther MD, MSc, FRCPC Professor Division Director1,2,
- Jeff Ginsberg MD, FRCPC Professor3,
- Holger J. Schünemann MD, PhD, MSc, FACP, FCCP Professor4,5,
- Ralph M. Meyer MD, FRCPC Director Professor6,7,
- Richard Lottenberg MD, FACP Professor8
Published Online: 4 FEB 2009
DOI: 10.1002/9781444300857.ch46
Copyright © 2008 Blackwell Publishing Ltd
Book Title

Evidence-Based Hematology
Additional Information
How to Cite
Meyer, R. M. (2009) Selected Management Issues of Patients with Hodgkin Lymphoma, in Evidence-Based Hematology (eds M. A. Crowther, J. Ginsberg, H. J. Schünemann, R. M. Meyer and R. Lottenberg), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444300857.ch46
Editor Information
- 1
Division of Hematology, McMaster University, Hamilton, Ontario, Canada
- 2
St. Joseph's Hospital, Hamilton, Ontario, Canada
- 3
Department of Medicine, McMaster University, Hamilton, Canada
- 4
CLARITY Research Group, Department of Epidemiology, Italian National Cancer Institute Regina Elena, Rome, Italy
- 5
McMaster University, Hamilton, Canada
- 6
National Cancer Institute of Canada, Clinical Trials Group, Edith Eisenhauer Chair in Clinical Cancer Research, Queen's University, Kingston, Ontario, Canada
- 7
Departments of Oncology and Medicine, Queen's University, Kingston, Ontario, Canada
- 8
Division of Hematology/Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, Florida, USA
Publication History
- Published Online: 4 FEB 2009
- Published Print: 27 JUN 2008
ISBN Information
Print ISBN: 9781405157476
Online ISBN: 9781444300857
- Summary
- Chapter
Keywords:
- management of Hodgkin lymphoma;
- limited-stage Hodgkin lymphoma treated with combined-modality therapy;
- trials testing chemotherapy;
- optimum management of patients with untreated advanced-stage Hodgkin lymphoma;
- EORTC H8-F trial;
- BEACOPP;
- BEACOPP regimens with MOPP-ABVD-like regimen comparison;
- prednisone and procarbazine to ABV (ABVPP)
Summary
This chapter contains sections titled:
Introduction
Questions
Literature search and inclusion
What is optimum management of patients with previously untreated limited-stage Hodgkin lymphoma?
What is optimum management of patients with previously untreated advanced-stage Hodgkin lymphoma?
References
